Cancer clinical trials in the region Île-de-France
491 currently recruiting clinical trials
Looking for clinical trials?
Clinical trial search is a complex process, with countless criteria to consider. Our AI assistant navigates this complexity with precise, expert-level analysis of the most relevant trials based on your medical profile. Our database is fully up to date, so you see only actively recruiting sites. It's fast and easy:
- Create your account
- Copy-paste your latest medical report
- Our AI-based assistant does the rest for you
Whether you are a patient or a doctor, create an account to find and apply for the most relevant clinical trials:
Early Access
Lung cancer
NSCLC (Non-Small Cell Lung Cancer)
Non-squamous NSCLC
Locally Advanced
EGFR
None
Chemotherapy
Radiotherapy
AstraZeneca
Early Access
Lymphoma
B cell lymphoma
Large B cell lymphoma
2
3 or more
Systemic Treatment-Naive
Hoffmann-La Roche
Early Access
Lung cancer
SCLC (Small Cell Lung Cancer)
Localized
Locally Advanced
None
Chemotherapy
Radiotherapy
Chemotherapy
Radiotherapy
AstraZeneca
Early Access
Lung cancer
NSCLC (Non-Small Cell Lung Cancer)
Locally Advanced
Metastatic
EGFR
None
Systemic Treatment-Naive
Janssen
Early Access
Lung cancer
NSCLC (Non-Small Cell Lung Cancer)
Locally Advanced
Metastatic
EGFR
1
Targeted therapy
Systemic Treatment-Naive
Janssen
Early Access
Lymphoma
B cell lymphoma
Large B cell lymphoma
1
Systemic Treatment-Naive
Hoffmann-La Roche
Phase 3
Breast cancer
#NCT06760637
HER2 Negative
HR Positive
Locally Advanced
Metastatic
None
Systemic Treatment-Naive
Gustave Roussy (Villejuif), Institut Curie - Paris (Paris), Institut Curie (Saint Cloud) - Hôpital René Huguenin (Saint-Cloud)
Pfizer
Phase 3
Lung cancer
#NCT06119581
#2023-503412-33-00
NSCLC (Non-Small Cell Lung Cancer)
Locally Advanced
Metastatic
KRAS G12C
None
Systemic Treatment-Naive
BRAF
EGFR
HER2
MET
NTRK-1/2/3
RET
ROS-1
Immunotherapy
Chemotherapy
Targeted therapy
Gustave Roussy (Villejuif), Institut Curie - Paris (Paris), Hôpital Foch (Suresnes)
Eli Lilly et compagnie
Phase 3
Endometrial cancer
#NCT06952504
#2024-519331-42-00
Endometrioid adenocarcinoma
Serous adenocarcinoma
Clear cell carcinoma
Dedifferentiated and undifferentiated endometrial ...
Locally Advanced
Metastatic
MSS/pMMR
None
Systemic Treatment-Naive
MSI/dMMR
Immunotherapy
Antibody Drug Conjugates (ADC)
Immunotherapy
Antibody Drug Conjugates (ADC)
Groupe Hospitalier Diaconesses - Site Croix Saint Simon (Paris), Hôpital Cochin (Paris ), Institut Curie (Saint Cloud) - Hôpital René Huguenin (Saint-Cloud)
Merck Sharp & Dohme LLC
Phase 3
Lung cancer
#NCT07099898
#2025-521627-78
SCLC (Small Cell Lung Cancer)
Locally Advanced
Metastatic
1
Immunotherapy
Chemotherapy
Hôpital Ambroise-Paré AP-HP (Boulogne-Billancourt)
GlaxoSmithKline